#LungCancer investigators: LOIs are being accepted for 3 new grant mechanisms. A $300K 2yr award supports ALK+ NSCLC research. LCRF & AstraZeneca partnered on two SCLC-focused grants: a $500K 3yr award on treatments & a $250, 2yr award to improve outcomes through patient advocacy. LCRF.org/funding
LCRF offers lung cancer research funding opportunities. Read about current Requests for Proposals, deadlines, and requirements.
